- Home
- UUU vs GLMD Comparison
UUU vs GLMD Comparison
Compare UUU & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- GLMD
- Stock Information
- Founded
- UUU 1969
- GLMD 2000
- Country
- UUU United States
- GLMD Israel
- Employees
- UUU N/A
- GLMD N/A
- Industry
- UUU Electronic Components
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- GLMD Health Care
- Exchange
- UUU Nasdaq
- GLMD Nasdaq
- Market Cap
- UUU 9.8M
- GLMD 8.0M
- IPO Year
- UUU N/A
- GLMD 2014
- Fundamental
- Price
- UUU N/A
- GLMD N/A
- Analyst Decision
- UUU
- GLMD Hold
- Analyst Count
- UUU 0
- GLMD 1
- Target Price
- UUU N/A
- GLMD N/A
- AVG Volume (30 Days)
- UUU 251.5K
- GLMD 71.0K
- Earning Date
- UUU 11-18-2025
- GLMD 11-13-2025
- Dividend Yield
- UUU 22.57%
- GLMD N/A
- EPS Growth
- UUU N/A
- GLMD N/A
- EPS
- UUU 1.19
- GLMD N/A
- Revenue
- UUU $22,789,285.00
- GLMD N/A
- Revenue This Year
- UUU N/A
- GLMD N/A
- Revenue Next Year
- UUU N/A
- GLMD N/A
- P/E Ratio
- UUU $3.70
- GLMD N/A
- Revenue Growth
- UUU 30.84
- GLMD N/A
- 52 Week Low
- UUU $1.15
- GLMD $1.15
- 52 Week High
- UUU $8.27
- GLMD $4.81
- Technical
- Relative Strength Index (RSI)
- UUU 44.79
- GLMD N/A
- Support Level
- UUU $4.40
- GLMD N/A
- Resistance Level
- UUU $5.03
- GLMD N/A
- Average True Range (ATR)
- UUU 0.64
- GLMD 0.00
- MACD
- UUU -0.25
- GLMD 0.00
- Stochastic Oscillator
- UUU 10.93
- GLMD 0.00
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.